Velakor Biotherapeutics Inc
New York, United States · Founded 2025
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2025
- Business Model
- B2B
- Website
- velakorbio.com
About
Velakor Biotherapeutics is a clinical-stage biotherapeutics company developing CAM-6019, a novel Agrin-derived biologic therapy designed to promote cardiac regeneration and repair following ischemic heart disease. Founded as a Cambrian Bio incubated company, Velakor's approach mimics the young, pro-regenerative extracellular matrix (ECM) to activate the heart's innate regenerative capabilities. CAM-6019 has demonstrated successful cardiac regeneration in translatable porcine models of STEMI and heart failure.
Summary
Velakor Biotherapeutics Inc is a Biotech company based in New York, United States, founded in 2025.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/velakor-biotherapeutics-inc"><img src="https://indexed.vc/api/badge/company/velakor-biotherapeutics-inc" alt="Velakor Biotherapeutics Inc on Indexed.vc" width="260" height="76" /></a>